<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="27844">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02744235</url>
  </required_header>
  <id_info>
    <org_study_id>15-00071</org_study_id>
    <nct_id>NCT02744235</nct_id>
  </id_info>
  <brief_title>Mainstream Sleep Tracking Devices vs Polysomnography</brief_title>
  <official_title>Sensitivity and Specificity of Mainstream Sleep Tracking Devices Compared to Polysomnography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare two popular portable sleep monitoring devices—the
      Fitbit Charge®, Jawbone UP®, and SleepTime smartphone app—to the &quot;gold standard&quot;
      Polysomnography (PSG). Parameters that will be analyzed include sleep onset latency, sleep
      efficiency, and sleep staging. Specifically, this study will investigate the validity of the
      Jawbone UP®, Fitbit Charge®, and SleepTime app in detecting sleep and wakefulness in
      comparison to conventional Polysomnography (PSG).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time it takes subject to fall asleep</measure>
    <time_frame>Up to 3 Months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Minutes of Sleep</measure>
    <time_frame>Up to 3 Months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Arousals</measure>
    <time_frame>Up to 3 Months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Severe Sleep Apnea</condition>
  <condition>Severe Insomnia</condition>
  <condition>Epileptiform Activity</condition>
  <arm_group>
    <arm_group_label>Patients undergoing Polysomnography</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Polysomnography Data</intervention_name>
    <arm_group_label>Patients undergoing Polysomnography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Jawbone UP®</intervention_name>
    <arm_group_label>Patients undergoing Polysomnography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fitbit Charge ®</intervention_name>
    <arm_group_label>Patients undergoing Polysomnography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing Polysomnography

        Exclusion Criteria:

          -  severe sleep apnea

          -  severe insomnia with less than two hours of sleep per night

          -  epileptiform activity

          -  electrical status epilepticus of sleep
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alcibiades Rodriguez</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vicky Chiang</last_name>
    <email>vc936@nyumc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Melissa Bernbaum</last_name>
    <email>bernbm01@nyumc.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Bernbaum</last_name>
      <email>bernbm01@nyumc.org</email>
    </contact>
    <contact_backup>
      <last_name>Vicky Chiang</last_name>
      <email>vc936@nyumc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Alcibiades Rodriguez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 28, 2016</lastchanged_date>
  <firstreceived_date>April 13, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
